retatrutide approval 2025 status october The FDA has issued warning letters to multiple companies marketing compounded Retatrutide for Weight Loss: TRIUMPH-1

At RescueMD, we provide a physician-supervised, evidence-based approach designed for sustainable results

Weeks 14: 3 mg, once daily Weeks 5 and onward (maintenance): 4 mg, once daily Medication is prescribed only after consultation with a licensed provider to determine appropriateness

Mean change in body weight was the trials primary endpoint

It is the only multi-peptide fat-loss stack with Phase 3 data

Serious but Rare Side Effects Less than 1% of patients experience serious side effects, which may include: Pancreatitis Severe abdominal pain that requires immediate medical attention

Phase 2 randomized controlled trial enrolled 338 adults with a BMI of 30 or higher (or 27 with at least one weight-related comorbidity) and without type 2 diabetes [1]